References

Maternal obesity alters histone modifications mediated by the interaction between EZH2 and AMPK, impairing neural differentiation in the developing embryonic brain cortex

10.1016/j.jbc.2025.108173 · 2025 · External reference

Cingulate microstimulation induces negative decision-making via reduced top-down influence on primate fronto-cingulo-striatal network

10.1038/s41467-024-48375-1 · 2024 · External reference

Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors

10.2165/00003088-199631060-00004 · 1996 · External reference

Scale for suicide ideation: Psychometric properties of a self-report version

10.1002/1097-4679(198807)44:4<499::aid-jclp2270440404>3.0.co;2-6 · 1988 · External reference

Depression diagnosis: EEG-based cognitive biomarkers and machine learning

10.1016/j.bbr.2024.115325 · 2025 · External reference

Dopaminergic frontostriatal pathways in major depressive disorder and childhood sexual abuse: a multimodal neuroimaging investigation

10.1038/s41380-025-03218-3 · 2026 · External reference

Psychomotor retardation in depression: Biological underpinnings, measurement, and treatment

10.1016/j.pnpbp.2010.10.019 · 2011 · External reference

Neuronal Oscillations in Cortical Networks

10.1126/science.1099745 · 2004 · External reference

Scoring higher the second time around: Meta-analyses of practice effects in neuropsychological assessment

10.1080/13854046.2012.680913 · 2012 · External reference

Global economic burden of depression in 154 countries from 2025 to 2050

10.1038/s41591-026-04548-7 · 2026 · External reference

Alteration of whole-brain amplitude of low-frequency fluctuation and degree centrality in patients with mild to moderate depression: A resting-state functional magnetic resonance imaging study

10.3389/fpsyt.2022.1061359 · 2022 · External reference

Characterizing Typhoon-related Posttraumatic Stress Disorder Based on Multimodal Fusion of Structural, Diffusion, and Functional Magnetic Resonance Imaging

10.1016/j.neuroscience.2023.11.018 · 2024 · External reference

Emerging strategies and clinical recommendations for the management of novel depression subtypes

10.1080/14737175.2025.2470973 · 2025 · External reference

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

10.1016/s0140-6736(17)32802-7 · 2018 · External reference

Longitudinal change in performance on the montreal cognitive assessment in older adults

10.1080/13854046.2015.1087596 · 2015 · External reference

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial

10.1001/jamapsychiatry.2017.3739 · 2018 · External reference

Cognitive decline is associated with frequency-specific resting state functional changes in normal aging

10.1007/s11682-022-00682-1 · 2022 · External reference

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

10.1038/s41380-018-0256-5 · 2020 · External reference

What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?

10.1038/s41386-024-01976-2 · 2025 · External reference

Decreased resting-state neural signal in the left angular gyrus as a potential neuroimaging biomarker of schizophrenia: An amplitude of low-frequency fluctuation and support vector machine analysis

10.3389/fpsyt.2022.949512 · 2022 · External reference

RETRACTED: Transcriptional correlates of frequency-dependent brain functional activity associated with symptom severity in degenerative cervical myelopathy

10.1016/j.neuroimage.2023.120451 · 2023 · External reference

The neurodegenerative hypothesis of depression and the influence of antidepressant medications

10.1016/j.ejphar.2024.176967 · 2024 · External reference

10.1037/t04100-000

10.1037/t04100-000 · External reference

Exploring the correlation between frequency-dependent brain activity and cognitive function in social anxiety disorder

10.1016/j.brainresbull.2025.111603 · 2025 · External reference

Frequency-dependent alterations in functional connectivity in patients with Alzheimer’s Disease spectrum disorders

10.3389/fnagi.2024.1375836 · 2024 · External reference

Impaired visual-motor functional connectivity in first-episode medication-naïve patients with major depressive disorder

10.1093/cercor/bhad387 · 2024 · External reference

Effects of esketamine on depression-like behavior and dendritic spine plasticity in the prefrontal cortex neurons of spared nerve injury-induced depressed mice

10.1590/1414-431x2024e13736 · 2024 · External reference

Amplitude of low-frequency fluctuation (ALFF) alterations in adults with subthreshold depression after physical exercise: A resting-state fMRI study

10.1016/j.jad.2021.08.094 · 2021 · External reference

Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder

10.1176/appi.ajp.2015.15030331 · 2016 · External reference

The effects of ketamine and esketamine on functional outcomes in major depressive disorder and treatment-resistant depression: A systematic review

10.1016/j.jpsychires.2025.10.056 · 2026 · External reference

Esketamine alleviates depressive-like behavior in neuropathic pain mice through the METTL3-GluA1 pathway

10.1007/s10565-024-09975-1 · 2025 · External reference

Local brain abnormalities in emotional disorders: Evidence from resting state fMRI studies

10.1002/wcs.1694 · 2024 · External reference

The N -methyl- d -aspartate receptor hypothesis of ketamine’s antidepressant action: evidence and controversies

10.1098/rstb.2023.0225 · 2024 · External reference

Ketamine in neuropsychiatric disorders: an update

10.1038/s41386-023-01632-1 · 2024 · External reference

Exploring Esketamine’s Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review

2024 · External reference

Novel rapid treatment options for adolescent depression

10.1016/j.phrs.2024.107085 · 2024 · External reference

Large‐scale dynamic causal modeling of major depressive disorder based on resting‐state functional magnetic resonance imaging

10.1002/hbm.24845 · 2020 · External reference

Effects of esketamine on electrophysiology and metabolic reprogramming in brain organoids: insights into antidepressant mechanisms

10.1038/s41380-025-03198-4 · 2025 · External reference

Changes in the amplitude of low-frequency fluctuations in specific frequency bands in major depressive disorder after electroconvulsive therapy

10.5498/wjp.v12.i5.708 · 2022 · External reference

Structural neural plasticity evoked by rapid-acting antidepressant interventions

10.1038/s41583-024-00876-0 · 2025 · External reference

Antidepressant effects of esketamine are associated with functional connectivity in the hippocampal subregion: A resting state magnetic resonance study

10.1016/j.neuroscience.2025.07.016 · 2025 · External reference

The altered multiscale dynamics of spontaneous brain activity in depression with Parkinson’s disease

10.1007/s10072-022-05974-4 · 2022 · External reference

The power of many brains: Catalyzing neuropsychiatric discovery through open neuroimaging data and large-scale collaboration

10.1016/j.scib.2024.03.006 · 2024 · External reference

Abnormal amygdala functional connectivity and deep learning classification in multifrequency bands in autism spectrum disorder: A multisite functional magnetic resonance imaging study

10.1002/hbm.26141 · 2023 · External reference

Ketamine/esketamine pharmacotherapy for treatment of anxiety disorders and anxiety symptoms in depression: Systematic review

2025 · External reference

Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder

10.1097/hrp.0000000000000171 · 2018 · External reference

Amplitude of low‐frequency fluctuations on Alzheimer’s disease with depression: evidence from resting‐state fMRI

10.1136/gpsych-2019-100147 · 2020 · External reference

Age exacerbates the negative effect of depression on executive functioning in racial and ethnic minorities

10.1007/s11682-024-00898-3 · 2024 · External reference

Validation of the Chinese version of Addenbrooke’s cognitive examination III for detecting mild cognitive impairment

10.1080/13607863.2021.1881757 · 2022 · External reference

The role of histone modifications: from neurodevelopment to neurodiseases

10.1038/s41392-022-01078-9 · 2022 · External reference

Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis

10.3389/fnbeh.2023.1282242 · 2024 · External reference

Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy

10.1007/s40262-016-0383-6 · 2016 · External reference

Surface-based functional brain imaging analysis of major depressive disorder after electroconvulsive therapy

10.1016/j.jad.2025.119492 · 2025 · External reference

Differential brain activity in patients with disorders of consciousness: a 3-month rs-fMRI study using amplitude of low-frequency fluctuation

10.3389/fneur.2024.1477596 · 2024 · External reference

Alterations of the amplitude of low-frequency fluctuation induced by repetitive transcranial magnetic stimulation combined with antidepressants treatment for major depressive disorder

2024 · External reference

Aberrant Neural Activity in Patients With Bipolar Depressive Disorder Distinguishing to the Unipolar Depressive Disorder: A Resting-State Functional Magnetic Resonance Imaging Study

10.3389/fpsyt.2018.00238 · 2018 · External reference

A schizophrenia study based on multi-frequency dynamic functional connectivity analysis of fMRI

10.3389/fnhum.2023.1164685 · 2023 · External reference

Metabolomics in Depression: What We Learn from Preclinical and Clinical Evidences

10.1007/s12035-024-04302-5 · 2025 · External reference

Prefrontal neurophysiological changes associated with subanesthetic esketamine accelerating mice emergence from propofol anesthesia

10.1016/j.brainresbull.2025.111648 · 2025 · External reference

Modulation of habenular and nucleus accumbens functional connectivity by ketamine in major depression

10.1002/brb3.3511 · 2024 · External reference

Alterations in Cerebral Intrinsic Activity in First-Episode, Drug-Naive Patients With Major Depressive Disorder

10.7759/cureus.83737 · 2025 · External reference

The role of frontal EEG in predicting clinical response of major depressive disorder to intranasal ketamine and esketamine

10.1016/j.jad.2025.120751 · 2026 · External reference

Structural brain alterations associated with suicidal thoughts and behaviors in young people: results from 21 international studies from the ENIGMA Suicidal Thoughts and Behaviours consortium

10.1038/s41380-022-01734-0 · 2022 · External reference

Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents

2022 · External reference

Longitudinal changes of amplitude of low-frequency fluctuations in MDD patients: A 6-month follow-up resting-state functional magnetic resonance imaging study

10.1016/j.jad.2020.07.067 · 2020 · External reference

Altered functional brain activity in first-episode major depressive disorder treated with electro-acupuncture: A resting-state functional magnetic resonance imaging study

2024 · External reference

Abnormal functional connectivity within the prefrontal cortex is associated with multiple plasma lipid species in major depressive disorder

10.1016/j.jad.2023.12.072 · 2024 · External reference

Serotonin is a common thread linking different classes of antidepressants

10.1016/j.chembiol.2023.10.009 · 2023 · External reference

Unresolved reference

External reference

A Comprehensive Overview of the Role of Visual Cortex Malfunction in Depressive Disorders: Opportunities and Challenges

10.1007/s12264-023-01052-7 · 2023 · External reference

Frequency-dependent and time-variant alterations of neural activity in post-stroke depression: A resting-state fMRI study

2023 · External reference

A neuroimaging-based precision medicine framework for depression

10.1016/j.ajp.2023.103803 · 2024 · External reference

The Pathogenesis and Medical Treatment of Depression: Opportunity and Challenge

10.3390/neurolint17080120 · 2025 · External reference

Global, regional, and national incidence trends of depressive disorder, 1990–2019: An age-period-cohort analysis based on the Global Burden of Disease 2019 study

10.1016/j.genhosppsych.2024.03.003 · 2024 · External reference

DPABI: Data Processing & Analysis for (Resting-State) Brain Imaging

10.1007/s12021-016-9299-4 · 2016 · External reference

Frequency‐specific coactivation patterns in resting‐state and their alterations in schizophrenia: An fMRI study

10.1002/hbm.25884 · 2022 · External reference

Effects of subanesthetic repeated esketamine infusions on memory function and NGF in patients with depression: An open-label study

10.1016/j.jad.2024.09.162 · 2025 · External reference

Altered Spontaneous Brain Activity Patterns in Patients After Lasik Surgery Using Amplitude of Low-Frequency Fluctuation: A Resting-State Functional MRI Study

10.2147/ndt.s252850 · 2020 · External reference

Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI

10.1016/j.braindev.2006.07.002 · 2007 · External reference

A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

10.1001/archpsyc.63.8.856 · 2006 · External reference

Amplitude of Low-Frequency Oscillations in First-Episode Drug-Naive Patients with Major Depressive Disorder: A Resting State Functional Magnetic Resonance Imaging Study

10.2147/ndt.s348683 · 2022 · External reference

Consistent frontal-limbic-occipital connections in distinguishing treatment-resistant and non-treatment-resistant schizophrenia

2025 · External reference

Change in the global burden of depression from 1990-2019 and its prediction for 2030

10.1016/j.jpsychires.2024.07.054 · 2024 · External reference

Amplitude of brain low-frequency fluctuation and functional connectivity changes based on fMRI study in first-episode major depressive disorder

10.1016/j.clineuro.2025.109157 · 2025 · External reference

Abnormal amplitude of low-frequency fluctuation values as a neuroimaging biomarker for major depressive disorder with suicidal attempts in adolescents: A resting-state fMRI and support vector machine analysis

2023 · External reference

Distinctive intrinsic functional connectivity alterations of anterior cingulate cortex subdivisions in major depressive disorder: A systematic review and meta-analysis

10.1016/j.neubiorev.2024.105583 · 2024 · External reference

Transcriptomic decoding of regional cortical vulnerability to major depressive disorder

10.1038/s42003-024-06665-w · 2024 · External reference

Aberrant dynamic and static functional connectivity of the striatum across specific low-frequency bands in patients with autism spectrum disorder

2023 · External reference

An improved approach to detection of amplitude of low-frequency fluctuation (ALFF) for resting-state fMRI: Fractional ALFF

10.1016/j.jneumeth.2008.04.012 · 2008 · External reference

The oscillating brain: Complex and reliable

10.1016/j.neuroimage.2009.09.037 · 2010 · External reference